Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease

According to current recommendations, in addition to 13-valent pneumococcal conjugate vaccine (PCV13) series, all children with inflammatory bowel disease (IBD) aged ≥2 years, with planned or current immunosuppression, should receive pneumococcal polysaccharide vaccine (PPSV23). The primary aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Temtem, Tsega, Whitworth, John, Bagga, Bindiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537249/
https://www.ncbi.nlm.nih.gov/pubmed/31205985
http://dx.doi.org/10.1177/2333794X19849754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537249/
https://www.ncbi.nlm.nih.gov/pubmed/31205985
http://dx.doi.org/10.1177/2333794X19849754

Ejemplares similares